Page last updated: 2024-08-02 03:56:58

5-(2-bromovinyl)-2'-deoxyuridylate

Description

5-(2-bromovinyl)-2'-deoxyuridylate: RN given refers to cpd without isomeric designation [MeSH]

Cross-References

ID SourceID
PubMed CID6505368
CHEMBL ID1231519
SCHEMBL ID5009511
SCHEMBL ID4265437
MeSH IDM0118841

Synonyms (19)

Synonym
5'-uridylic acid, 5-(2-bromoethenyl)-2'-deoxy-
83378-41-0
5-(2-bromovinyl)-2'-deoxyuridylate
CHEMBL1231519
bvdu 5'-monophosphate
brivudine monophosphate
DB04438
bvdu-mp
brvdump
o7n0y11u8k ,
5'-uridylic acid, 5-((1e)-2-bromoethenyl)-2'-deoxy-
unii-o7n0y11u8k
80860-82-8
SCHEMBL5009511
SCHEMBL4265437
(e)-5-(2-bromovinyl)-2'-deoxyuridine monophosphate
5-[(e)-2-bromoethenyl]-2'-deoxyuridine 5'-(dihydrogen phosphate)
Q27285444
((2r,3s,5r)-5-(5-((e)-2-bromovinyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate

Bioassays (10)

Assay IDTitleYearJournalArticle
AID74257The compound was tested for inhibition of the rate of 1 uM UDP-[3H]-GlcNAc import into the lumen of the Golgi membranes.1996Journal of medicinal chemistry, Jul-19, Volume: 39, Issue:15
ISSN: 0022-2623
Inhibition of UDP-N-acetylglucosamine import into Golgi membranes by nucleoside monophosphates.
AID87826Evaluation of antiviral activity against Herpes simplex virus type 2 (HSV-2) strain 196.1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
ISSN: 0022-2623
Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters.
AID87827Evaluation of antiviral activity against Herpes simplex virus type 2 (HSV-2) strain G1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
ISSN: 0022-2623
Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters.
AID87508Evaluation of antiviral activity against Herpes simplex virus type 1 (HSV-1) strain McIntyre1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
ISSN: 0022-2623
Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters.
AID216539Evaluation of antiviral activity against Vesicular stomatitis virus.1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
ISSN: 0022-2623
Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters.
AID74254Inhibitory concentration at which there is accumulation of UDP-[3H]-GlcNAc in the lumen of the Golgi membranes; Not determined1996Journal of medicinal chemistry, Jul-19, Volume: 39, Issue:15
ISSN: 0022-2623
Inhibition of UDP-N-acetylglucosamine import into Golgi membranes by nucleoside monophosphates.
AID87828Evaluation of antiviral activity against Herpes simplex virus type 2 (HSV-2) strain Lyons1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
ISSN: 0022-2623
Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters.
AID87507Evaluation of antiviral activity against Herpes simplex virus type 1 (HSV-1) strain KOS.1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
ISSN: 0022-2623
Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters.
AID87506Evaluation of antiviral activity against Herpes simplex virus type 1 (HSV-1) strain F1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
ISSN: 0022-2623
Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters.
AID218132Evaluation of antiviral activity against Vaccinia virus1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
ISSN: 0022-2623
Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters.

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
floxuridinenucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
radiosensitizing agent
1986198638.0low010000
idoxuridineorganoiodine compound;
pyrimidine 2'-deoxyribonucleoside
antiviral drug;
DNA synthesis inhibitor
1986198638.0low010000
bromodeoxyuridinepyrimidine 2'-deoxyribonucleosideantimetabolite;
antineoplastic agent
1986198638.0low010000
cytidine monophosphatecytidine 5'-phosphate;
pyrimidine ribonucleoside 5'-monophosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite
1996199628.0low001000
cytidine diphosphatecytidine 5'-phosphate;
pyrimidine ribonucleoside 5'-diphosphate
Escherichia coli metabolite;
mouse metabolite
1996199628.0low001000
trifluridinenucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
EC 2.1.1.45 (thymidylate synthase) inhibitor
1986198638.0low010000
fluorodeoxyuridylatepyrimidine 2'-deoxyribonucleoside 5'-monophosphate1986198638.0low010000
thymidine monophosphatethymidine 5'-monophosphatefundamental metabolite1996199628.0low001000
2'-deoxyuridylic aciddeoxyuridine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-monophosphate
Escherichia coli metabolite;
metabolite;
mouse metabolite
1996199628.0low001000
3'-azido-3'-deoxythymidine 5'phosphate1996199628.0low001000
5-chloro-2'-deoxyuridine1986198638.0low010000
bromodeoxyuridylate1986198638.0medium010000
uridine diphosphate galactosamineUDP-amino sugar1996199628.0medium001000
5-trifluoromethyl-2'-deoxyuridylic acid1986198638.0medium010000
udp-glucosamineUDP-amino sugar1996199628.0low001000
brivudine1986198638.0low010000
cytidine monophosphate n-acetylneuraminic acidCMP-N-acyl-beta-neuraminic acidmouse metabolite1996199628.0low001000
5-iodo-2'-deoxyuridine 5'-monophosphate1986198638.0medium010000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
cycloheximideantibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol
anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
1986198638.0low010000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Cytomegalovirus01986198638.0high010000
Leukemia L 121001986198638.0high010000